Mouse Anti-LPCAT1 Recombinant Antibody (CBYCL-435) (CBMAB-L0336-YC)

Name: Mouse Anti-LPCAT1 Recombinant Antibody (CBYCL-435)
SKU: CBMAB-L0336-YC
Rating: 5 (1 reviews)

See all LPCAT1 antibodies

Compare Online Inquiry

Datasheet

SDS

Request for COA

Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Host Animal

Mouse

Clone

CBYCL-435

Application

ELISA, WB, IF

Specificity

Human

Antibody Isotype

IgG2a

Clonality

Monoclonal

Application Notes

The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Storage

Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

More Infomation

Target

Full Name

LPCAT1

Introduction

LPCAT1 is a member of the 1-acyl-sn-glycerol-3-phosphate acyltransferase family of proteins. The encoded enzyme plays a role in phospholipid metabolism, specifically in the conversion of lysophosphatidylcholine to phosphatidylcholine in the presence of acyl-CoA. This process is important in the synthesis of lung surfactant and platelet-activating factor (PAF). Elevated expression of this gene may contribute to the progression of oral squamous cell, prostate, breast, and other human cancers.

Entrez Gene ID

79888

UniProt ID

Q8NF37

Alternative Names

AGPAT10; AGPAT9; AYTL2; LPCAT-1; PFAAP3; lpcat; lysoPAFAT

Function

Exhibits acyltransferase activity (PubMed:21498505, PubMed:18156367).
Exhibits acetyltransferase activity (By similarity).
Activity is calcium-independent (By similarity).
Catalyzes the conversion of lysophosphatidylcholine (1-acyl-sn-glycero-3-phosphocholine or LPC) into phosphatidylcholine (1,2-diacyl-sn-glycero-3-phosphocholine or PC) (PubMed:21498505, PubMed:18156367).
Catalyzes the conversion 1-acyl-sn-glycerol-3-phosphate (lysophosphatidic acid or LPA) into 1,2-diacyl-sn-glycerol-3-phosphate (phosphatidic acid or PA) by incorporating an acyl moiety at the sn-2 position of the glycerol backbone (By similarity).
Displays a clear preference for saturated fatty acyl-CoAs, and 1-myristoyl or 1-palmitoyl LPC as acyl donors and acceptors, respectively (By similarity).
Involved in platelet-activating factor (PAF) biosynthesis by catalyzing the conversion of the PAF precursor, 1-O-alkyl-sn-glycero-3-phosphocholine (lyso-PAF) into 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (PAF) (By similarity).
May synthesize phosphatidylcholine in pulmonary surfactant, thereby playing a pivotal role in respiratory physiology (By similarity).
Involved in the regulation of lipid droplet number and size (PubMed:25491198).

Biological Process

Negative regulation of phosphatidylcholine biosynthetic processIEA:Ensembl
Phosphatidic acid biosynthetic processTAS:Reactome
Phosphatidylcholine acyl-chain remodelingManual Assertion Based On ExperimentIDA:UniProtKB
Phosphatidylglycerol acyl-chain remodelingTAS:Reactome
Phospholipid biosynthetic processISS:UniProtKB
Positive regulation of protein catabolic processIEA:Ensembl
Retina development in camera-type eyeIEA:Ensembl
Surfactant homeostasisIEA:Ensembl

Cellular Location

Endoplasmic reticulum membrane
Golgi apparatus membrane
Cell membrane
Lipid droplet
May adopt a monotopic topology when embedded in the lipid monolayer of the lipid droplet, with both termini exposed to the cytoplasm.

Topology

Cytoplasmic: 1-57
Helical: 58-78
Lumenal: 79-534

Huang, Y., Wang, Y., Wang, Y., Wang, N., Duan, Q., Wang, S., ... & Zheng, Y. (2022). LPCAT1 promotes cutaneous squamous cell carcinoma via EGFR-mediated protein kinase B/p38MAPK signaling pathways. Journal of Investigative Dermatology, 142(2), 303-313.

Ding, J., Ding, X., & Leng, Z. (2022). LPCAT1 promotes gefitinib resistance via upregulation of the EGFR/PI3K/AKT signaling pathway in lung adenocarcinoma. Journal of Cancer, 13(6), 1837.

He, R. Q., Li, J. D., Du, X. F., Dang, Y. W., Yang, L. J., Huang, Z. G., ... & Chen, G. (2021). LPCAT1 overexpression promotes the progression of hepatocellular carcinoma. Cancer cell international, 21(1), 1-17.

Tao, M., Luo, J., Gu, T., Yu, X., Song, Z., Jun, Y., ... & Wang, Q. (2021). LPCAT1 reprogramming cholesterol metabolism promotes the progression of esophageal squamous cell carcinoma. Cell death & disease, 12(9), 845.

Wang, K., Wu, Z., Si, Y., Tang, W., Xu, X., Cheng, Y., & Lin, J. (2021). Identification of LPCAT1 expression as a potential prognostic biomarker guiding treatment choice in acute myeloid leukemia. Oncology Letters, 21(2), 1-1.

Ji, W., Peng, Z., Sun, B., Chen, L., Zhang, Q., Guo, M., & Su, C. (2021). LpCat1 promotes malignant transformation of hepatocellular carcinoma cells by directly suppressing STAT1. Frontiers in Oncology, 11, 678714.

Liu, Y., Yang, C., Zhang, Z., & Jiang, H. (2021). Gut microbiota dysbiosis accelerates prostate cancer progression through increased LPCAT1 expression and enhanced DNA repair pathways. Frontiers in oncology, 11, 679712.

Han, C., Yu, G., Mao, Y., Song, S., Li, L., Zhou, L., ... & Xu, B. (2020). LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production. PLoS One, 15(11), e0240801.

Wei, C., Dong, X., Lu, H., Tong, F., Chen, L., Zhang, R., ... & Dong, X. (2019). LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway. Journal of Experimental & Clinical Cancer Research, 38(1), 1-16.

Lebok, P., von Hassel, A., Meiners, J., Hube-Magg, C., Simon, R., Höflmayer, D., ... & Burandt, E. C. (2019). Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer. Aging (Albany NY), 11(18), 7796.

Ask a question We look forward to hearing from you.

0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Have you used Mouse Anti-LPCAT1 Recombinant Antibody (CBYCL-435)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

$30 eGift Card
Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols

Related Products

Mouse Anti-LPCAT1 Recombinant Antibody (A918) (CAT#: CBMAB-AP11505LY)

Mouse Anti-LPCAT1 Recombinant Antibody (CF271) (CAT#: CBMAB-FT231LY)

Mouse Anti-LPCAT1 Recombinant Antibody (CBYJL-1916) (CAT#: CBMAB-L1950-YJ)

Isotype control

For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Request bulk or custom quote Second antibody and isotype control

Contact us

Tel: (USA)
(UK)
Fax:

Global Locations

Email:

Online Inquiry